InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Abingworth LLP. Insider active across 3 companies, notably Vera Therapeutics, Inc.. Aggregated, 5 filings have been published. The latest transaction was disclosed on 28 January 2022 — X. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
7,720,000 shares
Common Stock
SEC:0000905718-22-000523:0·
Ideal exit: 24 Dec 2022 (T+270)
€3m287,471 shares@ €11.841750.0% of flow
Common Stock, $0.001 par value
SEC:0000905718-22-000177:0·
€3m287,471 shares@ €11.8417100.0% of flow
Common Stock, $0.001 par value
SEC:0000905718-22-000177·
2,187,504 shares
Class A Common Stock
SEC:0000905718-21-000712·
2,187,504 shares
Class A Common Stock
SEC:0000905718-21-000712:0·
5 of 5 declarations
About Abingworth LLP
Abingworth LLP is a director and insider for Vera Therapeutics, Inc., Sierra Oncology, Inc., and Soleno Therapeutics INC.
